InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Karl Mahler, 管理人员. Director active across 1 company, notably Marinomed Biotech AG. In total, 3 filings have been logged. History available since 8 January 2025. The latest transaction was disclosed on 31 March 2026 (Other). Regulator: FMA (OeKB OAM). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Karl Mahler is an Executive at Marinomed Biotech AG. In this role, he is involved in the strategic management of the company and contributes to key decision-making. His experience in the biopharmaceutical sector allows him to play a crucial role in the direction and growth of Marinomed. Karl is committed to promoting sustainable and responsible practices.